img

Global Aluminum Adjuvanted Vaccines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aluminum Adjuvanted Vaccines Market Insights, Forecast to 2034

The mechanism of action of aluminum adjuvant mainly includes storage effect and immunostimulatory effect. Aluminum adjuvant can also stimulate innate immunity and induce monocytes to secrete IL-1β and IL-18 by activating Nlrp3 inflammasome. In addition, aluminum adjuvant can stimulate necrotic cells at the injection site to release damage-associated pattern molecules (DAMPs) such as DNA, ATP, and uric acid, and the released DAMPs help the interaction between dendritic cells and CD4+ T cells.
Global Aluminum Adjuvanted Vaccines market is expected to reach to US$ 710 million in 2023, with a positive growth of %, compared with US$ 650 million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Aluminum Adjuvanted Vaccines industry is evaluated to reach US$ 1210.5 million in 2034. The CAGR will be 9.3% during 2023 to 2034.
Vaccination programs are essential for the prevention of infectious diseases, and aluminum adjuvanted vaccines play an important role in many immunization programs. Rising awareness regarding the importance of vaccination and expanding vaccination programs across the globe is boosting the demand for aluminum adjuvanted vaccines.
Report Covers
This report presents an overview of global Aluminum Adjuvanted Vaccines market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Aluminum Adjuvanted Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Emergent BioSolutions
Sanofi
GlaxoSmithKline Biologicals
Pfizer
Merck
Wyeth Pharmaceuticals
Segment by Type
Aluminum Phosphate
Aluminum Hydroxide
Potassium Aluminum Sulfate

Segment by Application


Hospital
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Aluminum Adjuvanted Vaccines plant distribution, commercial date of Aluminum Adjuvanted Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Aluminum Adjuvanted Vaccines introduction, etc. Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Aluminum Adjuvanted Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Aluminum Adjuvanted Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Aluminum Adjuvanted Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Aluminum Phosphate
1.2.3 Aluminum Hydroxide
1.2.4 Potassium Aluminum Sulfate
1.3 Market by Application
1.3.1 Global Aluminum Adjuvanted Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Aluminum Adjuvanted Vaccines Sales Estimates and Forecasts 2018-2034
2.2 Global Aluminum Adjuvanted Vaccines Revenue by Region
2.2.1 Global Aluminum Adjuvanted Vaccines Revenue by Region: 2018 VS 2024 VS 2034
2.2.2 Global Aluminum Adjuvanted Vaccines Revenue by Region (2018-2023)
2.2.3 Global Aluminum Adjuvanted Vaccines Revenue by Region (2024-2034)
2.2.4 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Region (2018-2034)
2.3 Global Aluminum Adjuvanted Vaccines Sales Estimates and Forecasts 2018-2034
2.4 Global Aluminum Adjuvanted Vaccines Sales by Region
2.4.1 Global Aluminum Adjuvanted Vaccines Sales by Region: 2018 VS 2024 VS 2034
2.4.2 Global Aluminum Adjuvanted Vaccines Sales by Region (2018-2023)
2.4.3 Global Aluminum Adjuvanted Vaccines Sales by Region (2024-2034)
2.4.4 Global Aluminum Adjuvanted Vaccines Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Aluminum Adjuvanted Vaccines Sales by Manufacturers
3.1.1 Global Aluminum Adjuvanted Vaccines Sales by Manufacturers (2018-2023)
3.1.2 Global Aluminum Adjuvanted Vaccines Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aluminum Adjuvanted Vaccines in 2024
3.2 Global Aluminum Adjuvanted Vaccines Revenue by Manufacturers
3.2.1 Global Aluminum Adjuvanted Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Aluminum Adjuvanted Vaccines Revenue in 2024
3.3 Global Key Players of Aluminum Adjuvanted Vaccines, Industry Ranking, 2021 VS 2024 VS 2023
3.4 Global Aluminum Adjuvanted Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Aluminum Adjuvanted Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Aluminum Adjuvanted Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Aluminum Adjuvanted Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Aluminum Adjuvanted Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Aluminum Adjuvanted Vaccines Sales by Type
4.1.1 Global Aluminum Adjuvanted Vaccines Historical Sales by Type (2018-2023)
4.1.2 Global Aluminum Adjuvanted Vaccines Forecasted Sales by Type (2024-2034)
4.1.3 Global Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2034)
4.2 Global Aluminum Adjuvanted Vaccines Revenue by Type
4.2.1 Global Aluminum Adjuvanted Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global Aluminum Adjuvanted Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Aluminum Adjuvanted Vaccines Price by Type
4.3.1 Global Aluminum Adjuvanted Vaccines Price by Type (2018-2023)
4.3.2 Global Aluminum Adjuvanted Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Aluminum Adjuvanted Vaccines Sales by Application
5.1.1 Global Aluminum Adjuvanted Vaccines Historical Sales by Application (2018-2023)
5.1.2 Global Aluminum Adjuvanted Vaccines Forecasted Sales by Application (2024-2034)
5.1.3 Global Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2034)
5.2 Global Aluminum Adjuvanted Vaccines Revenue by Application
5.2.1 Global Aluminum Adjuvanted Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global Aluminum Adjuvanted Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Aluminum Adjuvanted Vaccines Price by Application
5.3.1 Global Aluminum Adjuvanted Vaccines Price by Application (2018-2023)
5.3.2 Global Aluminum Adjuvanted Vaccines Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Aluminum Adjuvanted Vaccines Market Size by Type
6.1.1 US & Canada Aluminum Adjuvanted Vaccines Sales by Type (2018-2034)
6.1.2 US & Canada Aluminum Adjuvanted Vaccines Revenue by Type (2018-2034)
6.2 US & Canada Aluminum Adjuvanted Vaccines Market Size by Application
6.2.1 US & Canada Aluminum Adjuvanted Vaccines Sales by Application (2018-2034)
6.2.2 US & Canada Aluminum Adjuvanted Vaccines Revenue by Application (2018-2034)
6.3 US & Canada Aluminum Adjuvanted Vaccines Market Size by Country
6.3.1 US & Canada Aluminum Adjuvanted Vaccines Revenue by Country: 2018 VS 2024 VS 2034
6.3.2 US & Canada Aluminum Adjuvanted Vaccines Sales by Country (2018-2034)
6.3.3 US & Canada Aluminum Adjuvanted Vaccines Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Aluminum Adjuvanted Vaccines Market Size by Type
7.1.1 Europe Aluminum Adjuvanted Vaccines Sales by Type (2018-2034)
7.1.2 Europe Aluminum Adjuvanted Vaccines Revenue by Type (2018-2034)
7.2 Europe Aluminum Adjuvanted Vaccines Market Size by Application
7.2.1 Europe Aluminum Adjuvanted Vaccines Sales by Application (2018-2034)
7.2.2 Europe Aluminum Adjuvanted Vaccines Revenue by Application (2018-2034)
7.3 Europe Aluminum Adjuvanted Vaccines Market Size by Country
7.3.1 Europe Aluminum Adjuvanted Vaccines Revenue by Country: 2018 VS 2024 VS 2034
7.3.2 Europe Aluminum Adjuvanted Vaccines Sales by Country (2018-2034)
7.3.3 Europe Aluminum Adjuvanted Vaccines Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Aluminum Adjuvanted Vaccines Market Size
8.1.1 China Aluminum Adjuvanted Vaccines Sales (2018-2034)
8.1.2 China Aluminum Adjuvanted Vaccines Revenue (2018-2034)
8.2 China Aluminum Adjuvanted Vaccines Market Size by Application
8.2.1 China Aluminum Adjuvanted Vaccines Sales by Application (2018-2034)
8.2.2 China Aluminum Adjuvanted Vaccines Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Aluminum Adjuvanted Vaccines Market Size by Type
9.1.1 Asia Aluminum Adjuvanted Vaccines Sales by Type (2018-2034)
9.1.2 Asia Aluminum Adjuvanted Vaccines Revenue by Type (2018-2034)
9.2 Asia Aluminum Adjuvanted Vaccines Market Size by Application
9.2.1 Asia Aluminum Adjuvanted Vaccines Sales by Application (2018-2034)
9.2.2 Asia Aluminum Adjuvanted Vaccines Revenue by Application (2018-2034)
9.3 Asia Aluminum Adjuvanted Vaccines Sales by Region
9.3.1 Asia Aluminum Adjuvanted Vaccines Revenue by Region: 2018 VS 2024 VS 2034
9.3.2 Asia Aluminum Adjuvanted Vaccines Revenue by Region (2018-2034)
9.3.3 Asia Aluminum Adjuvanted Vaccines Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Country: 2018 VS 2024 VS 2034
10.3.2 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Company Information
11.1.2 Emergent BioSolutions Overview
11.1.3 Emergent BioSolutions Aluminum Adjuvanted Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Emergent BioSolutions Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emergent BioSolutions Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Aluminum Adjuvanted Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Sanofi Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 GlaxoSmithKline Biologicals
11.3.1 GlaxoSmithKline Biologicals Company Information
11.3.2 GlaxoSmithKline Biologicals Overview
11.3.3 GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Biologicals Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Aluminum Adjuvanted Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Pfizer Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Overview
11.5.3 Merck Aluminum Adjuvanted Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Merck Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Wyeth Pharmaceuticals
11.6.1 Wyeth Pharmaceuticals Company Information
11.6.2 Wyeth Pharmaceuticals Overview
11.6.3 Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Wyeth Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Aluminum Adjuvanted Vaccines Industry Chain Analysis
12.2 Aluminum Adjuvanted Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Aluminum Adjuvanted Vaccines Production Mode & Process
12.4 Aluminum Adjuvanted Vaccines Sales and Marketing
12.4.1 Aluminum Adjuvanted Vaccines Sales Channels
12.4.2 Aluminum Adjuvanted Vaccines Distributors
12.5 Aluminum Adjuvanted Vaccines Customers
13 Market Dynamics
13.1 Aluminum Adjuvanted Vaccines Industry Trends
13.2 Aluminum Adjuvanted Vaccines Market Drivers
13.3 Aluminum Adjuvanted Vaccines Market Challenges
13.4 Aluminum Adjuvanted Vaccines Market Restraints
14 Key Findings in The Global Aluminum Adjuvanted Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Aluminum Adjuvanted Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Aluminum Phosphate
Table 3. Major Manufacturers of Aluminum Hydroxide
Table 4. Major Manufacturers of Potassium Aluminum Sulfate
Table 5. Global Aluminum Adjuvanted Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Aluminum Adjuvanted Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Aluminum Adjuvanted Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Aluminum Adjuvanted Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Region (2018-2023)
Table 10. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Region (2024-2034)
Table 11. Global Aluminum Adjuvanted Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 12. Global Aluminum Adjuvanted Vaccines Sales by Region (2018-2023) & (K Units)
Table 13. Global Aluminum Adjuvanted Vaccines Sales by Region (2024-2034) & (K Units)
Table 14. Global Aluminum Adjuvanted Vaccines Sales Market Share by Region (2018-2023)
Table 15. Global Aluminum Adjuvanted Vaccines Sales Market Share by Region (2024-2034)
Table 16. Global Aluminum Adjuvanted Vaccines Sales by Manufacturers (2018-2023) & (K Units)
Table 17. Global Aluminum Adjuvanted Vaccines Sales Share by Manufacturers (2018-2023)
Table 18. Global Aluminum Adjuvanted Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Aluminum Adjuvanted Vaccines Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Aluminum Adjuvanted Vaccines, Industry Ranking, 2021 VS 2024 VS 2023
Table 21. Aluminum Adjuvanted Vaccines Price by Manufacturers 2018-2023 (US$/Unit)
Table 22. Global Aluminum Adjuvanted Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Aluminum Adjuvanted Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aluminum Adjuvanted Vaccines as of 2024)
Table 24. Global Key Manufacturers of Aluminum Adjuvanted Vaccines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Aluminum Adjuvanted Vaccines, Product Offered and Application
Table 26. Global Key Manufacturers of Aluminum Adjuvanted Vaccines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 29. Global Aluminum Adjuvanted Vaccines Sales by Type (2024-2034) & (K Units)
Table 30. Global Aluminum Adjuvanted Vaccines Sales Share by Type (2018-2023)
Table 31. Global Aluminum Adjuvanted Vaccines Sales Share by Type (2024-2034)
Table 32. Global Aluminum Adjuvanted Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Aluminum Adjuvanted Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Aluminum Adjuvanted Vaccines Revenue Share by Type (2018-2023)
Table 35. Global Aluminum Adjuvanted Vaccines Revenue Share by Type (2024-2034)
Table 36. Aluminum Adjuvanted Vaccines Price by Type (2018-2023) & (US$/Unit)
Table 37. Global Aluminum Adjuvanted Vaccines Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. Global Aluminum Adjuvanted Vaccines Sales by Application (2024-2034) & (K Units)
Table 40. Global Aluminum Adjuvanted Vaccines Sales Share by Application (2018-2023)
Table 41. Global Aluminum Adjuvanted Vaccines Sales Share by Application (2024-2034)
Table 42. Global Aluminum Adjuvanted Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Aluminum Adjuvanted Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Aluminum Adjuvanted Vaccines Revenue Share by Application (2018-2023)
Table 45. Global Aluminum Adjuvanted Vaccines Revenue Share by Application (2024-2034)
Table 46. Aluminum Adjuvanted Vaccines Price by Application (2018-2023) & (US$/Unit)
Table 47. Global Aluminum Adjuvanted Vaccines Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. US & Canada Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 49. US & Canada Aluminum Adjuvanted Vaccines Sales by Type (2024-2034) & (K Units)
Table 50. US & Canada Aluminum Adjuvanted Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Aluminum Adjuvanted Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 52. US & Canada Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 53. US & Canada Aluminum Adjuvanted Vaccines Sales by Application (2024-2034) & (K Units)
Table 54. US & Canada Aluminum Adjuvanted Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Aluminum Adjuvanted Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 56. US & Canada Aluminum Adjuvanted Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 57. US & Canada Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Aluminum Adjuvanted Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 59. US & Canada Aluminum Adjuvanted Vaccines Sales by Country (2018-2023) & (K Units)
Table 60. US & Canada Aluminum Adjuvanted Vaccines Sales by Country (2024-2034) & (K Units)
Table 61. Europe Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 62. Europe Aluminum Adjuvanted Vaccines Sales by Type (2024-2034) & (K Units)
Table 63. Europe Aluminum Adjuvanted Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Aluminum Adjuvanted Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 65. Europe Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 66. Europe Aluminum Adjuvanted Vaccines Sales by Application (2024-2034) & (K Units)
Table 67. Europe Aluminum Adjuvanted Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Aluminum Adjuvanted Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 69. Europe Aluminum Adjuvanted Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 70. Europe Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Aluminum Adjuvanted Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 72. Europe Aluminum Adjuvanted Vaccines Sales by Country (2018-2023) & (K Units)
Table 73. Europe Aluminum Adjuvanted Vaccines Sales by Country (2024-2034) & (K Units)
Table 74. China Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 75. China Aluminum Adjuvanted Vaccines Sales by Type (2024-2034) & (K Units)
Table 76. China Aluminum Adjuvanted Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Aluminum Adjuvanted Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 78. China Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 79. China Aluminum Adjuvanted Vaccines Sales by Application (2024-2034) & (K Units)
Table 80. China Aluminum Adjuvanted Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Aluminum Adjuvanted Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 82. Asia Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 83. Asia Aluminum Adjuvanted Vaccines Sales by Type (2024-2034) & (K Units)
Table 84. Asia Aluminum Adjuvanted Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Aluminum Adjuvanted Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 86. Asia Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 87. Asia Aluminum Adjuvanted Vaccines Sales by Application (2024-2034) & (K Units)
Table 88. Asia Aluminum Adjuvanted Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Aluminum Adjuvanted Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 90. Asia Aluminum Adjuvanted Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 91. Asia Aluminum Adjuvanted Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Aluminum Adjuvanted Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 93. Asia Aluminum Adjuvanted Vaccines Sales by Region (2018-2023) & (K Units)
Table 94. Asia Aluminum Adjuvanted Vaccines Sales by Region (2024-2034) & (K Units)
Table 95. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 96. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Type (2024-2034) & (K Units)
Table 97. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 99. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Application (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 104. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 106. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Country (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales by Country (2024-2034) & (K Units)
Table 108. Emergent BioSolutions Company Information
Table 109. Emergent BioSolutions Description and Major Businesses
Table 110. Emergent BioSolutions Aluminum Adjuvanted Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Emergent BioSolutions Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Emergent BioSolutions Recent Developments
Table 113. Sanofi Company Information
Table 114. Sanofi Description and Major Businesses
Table 115. Sanofi Aluminum Adjuvanted Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sanofi Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sanofi Recent Developments
Table 118. GlaxoSmithKline Biologicals Company Information
Table 119. GlaxoSmithKline Biologicals Description and Major Businesses
Table 120. GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. GlaxoSmithKline Biologicals Recent Developments
Table 123. Pfizer Company Information
Table 124. Pfizer Description and Major Businesses
Table 125. Pfizer Aluminum Adjuvanted Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Pfizer Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Pfizer Recent Developments
Table 128. Merck Company Information
Table 129. Merck Description and Major Businesses
Table 130. Merck Aluminum Adjuvanted Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Merck Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Merck Recent Developments
Table 133. Wyeth Pharmaceuticals Company Information
Table 134. Wyeth Pharmaceuticals Description and Major Businesses
Table 135. Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Wyeth Pharmaceuticals Recent Developments
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Aluminum Adjuvanted Vaccines Distributors List
Table 141. Aluminum Adjuvanted Vaccines Customers List
Table 142. Aluminum Adjuvanted Vaccines Market Trends
Table 143. Aluminum Adjuvanted Vaccines Market Drivers
Table 144. Aluminum Adjuvanted Vaccines Market Challenges
Table 145. Aluminum Adjuvanted Vaccines Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Aluminum Adjuvanted Vaccines Product Picture
Figure 2. Global Aluminum Adjuvanted Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Aluminum Adjuvanted Vaccines Market Share by Type in 2024 & 2034
Figure 4. Aluminum Phosphate Product Picture
Figure 5. Aluminum Hydroxide Product Picture
Figure 6. Potassium Aluminum Sulfate Product Picture
Figure 7. Global Aluminum Adjuvanted Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Aluminum Adjuvanted Vaccines Market Share by Application in 2024 & 2034
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Aluminum Adjuvanted Vaccines Report Years Considered
Figure 12. Global Aluminum Adjuvanted Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Aluminum Adjuvanted Vaccines Revenue 2018-2034 (US$ Million)
Figure 14. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 15. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Region (2018-2034)
Figure 16. Global Aluminum Adjuvanted Vaccines Sales 2018-2034 ((K Units)
Figure 17. Global Aluminum Adjuvanted Vaccines Sales Market Share by Region (2018-2034)
Figure 18. US & Canada Aluminum Adjuvanted Vaccines Sales YoY (2018-2034) & (K Units)
Figure 19. US & Canada Aluminum Adjuvanted Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Aluminum Adjuvanted Vaccines Sales YoY (2018-2034) & (K Units)
Figure 21. Europe Aluminum Adjuvanted Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Aluminum Adjuvanted Vaccines Sales YoY (2018-2034) & (K Units)
Figure 23. China Aluminum Adjuvanted Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Asia (excluding China) Aluminum Adjuvanted Vaccines Sales YoY (2018-2034) & (K Units)
Figure 25. Asia (excluding China) Aluminum Adjuvanted Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Aluminum Adjuvanted Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 29. The Top 5 and 10 Largest Manufacturers of Aluminum Adjuvanted Vaccines in the World: Market Share by Aluminum Adjuvanted Vaccines Revenue in 2024
Figure 30. Global Aluminum Adjuvanted Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 31. Global Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2034)
Figure 32. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2034)
Figure 33. Global Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2034)
Figure 34. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2034)
Figure 35. US & Canada Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2034)
Figure 36. US & Canada Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2034)
Figure 37. US & Canada Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2034)
Figure 38. US & Canada Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada Aluminum Adjuvanted Vaccines Revenue Share by Country (2018-2034)
Figure 40. US & Canada Aluminum Adjuvanted Vaccines Sales Share by Country (2018-2034)
Figure 41. U.S. Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 42. Canada Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 43. Europe Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2034)
Figure 44. Europe Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2034)
Figure 45. Europe Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2034)
Figure 46. Europe Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2034)
Figure 47. Europe Aluminum Adjuvanted Vaccines Revenue Share by Country (2018-2034)
Figure 48. Europe Aluminum Adjuvanted Vaccines Sales Share by Country (2018-2034)
Figure 49. Germany Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 50. France Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 51. U.K. Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 52. Italy Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 53. Russia Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 54. China Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2034)
Figure 55. China Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2034)
Figure 56. China Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2034)
Figure 57. China Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2034)
Figure 58. Asia Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2034)
Figure 59. Asia Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2034)
Figure 60. Asia Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2034)
Figure 61. Asia Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2034)
Figure 62. Asia Aluminum Adjuvanted Vaccines Revenue Share by Region (2018-2034)
Figure 63. Asia Aluminum Adjuvanted Vaccines Sales Share by Region (2018-2034)
Figure 64. Japan Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 65. South Korea Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 66. China Taiwan Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 67. Southeast Asia Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 68. India Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Revenue Share by Country (2018-2034)
Figure 74. Middle East, Africa and Latin America Aluminum Adjuvanted Vaccines Sales Share by Country (2018-2034)
Figure 75. Brazil Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. Mexico Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. Turkey Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. Israel Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 79. GCC Countries Aluminum Adjuvanted Vaccines Revenue (2018-2034) & (US$ Million)
Figure 80. Aluminum Adjuvanted Vaccines Value Chain
Figure 81. Aluminum Adjuvanted Vaccines Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries